{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:30:48Z","timestamp":1762443048351,"version":"build-2065373602"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,6]]},"DOI":"10.7759\/cureus.96227","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:25:56Z","timestamp":1762442756000},"source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 and Stroke: Evaluating Correlations, Risk Factors, and Patient Outcomes"],"prefix":"10.7759","author":[{"given":"Hassan A","family":"Farid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samina","family":"Alim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiza","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali R","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B2000083","article-title":"An overview of COVID-19","volume":"21","author":"Shi Y","year":"2020","unstructured":"Shi Y, Wang G, Cai XP, et al.. An overview of COVID-19. J Zhejiang Univ Sci B. 2020, 21:343-60. 10.1631\/jzus.B2000083","journal-title":"J Zhejiang Univ Sci B"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/suab080","article-title":"Long COVID: long-term effects?","volume":"23","author":"Di Toro A","year":"2021","unstructured":"Di Toro A, Bozzani A, Tavazzi G, et al.. Long COVID: long-term effects?. Eur Heart J Suppl. 2021, 23:E1-5. 10.1093\/eurheartj\/suab080","journal-title":"Eur Heart J Suppl"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/v15020508","article-title":"Impact of COVID-19 on cardiovascular disease","volume":"15","author":"Vosko I","year":"2023","unstructured":"Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on cardiovascular disease. Viruses. 2023, 15:508. 10.3390\/v15020508","journal-title":"Viruses"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu Z","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, et al.. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020, 8:420-2. 10.1016\/S2213-2600(20)30076-X","journal-title":"Lancet Respir Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-016794","article-title":"Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist","volume":"13","author":"Zakeri A","year":"2021","unstructured":"Zakeri A, Jadhav AP, Sullenger BA, Nimjee SM. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. J Neurointerv Surg. 2021, 13:202-6. 10.1136\/neurintsurg-2020-016794","journal-title":"J Neurointerv Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6650","article-title":"COVID-19 is an independent risk factor for acute ischemic stroke","volume":"41","author":"Belani P","year":"2020","unstructured":"Belani P, Schefflein J, Kihira S, et al.. COVID-19 is an independent risk factor for acute ischemic stroke. AJNR Am J Neuroradiol. 2020, 41:1361-4. 10.3174\/ajnr.A6650","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-023-00336-5","article-title":"SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels","volume":"2","author":"Eberhardt N","year":"2023","unstructured":"Eberhardt N, Noval MG, Kaur R, et al.. SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. Nat Cardiovasc Res. 2023, 2:899-916. 10.1038\/s44161-023-00336-5","journal-title":"Nat Cardiovasc Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.031786","article-title":"Acute ischemic stroke and COVID-19: an analysis of 27\u2009676 patients","volume":"52","author":"Qureshi AI","year":"2021","unstructured":"Qureshi AI, Baskett WI, Huang W, et al.. Acute ischemic stroke and COVID-19: an analysis of 27\u2009676 patients. Stroke. 2021, 52:905-12. 10.1161\/STROKEAHA.120.031786","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-023-00837-w","article-title":"Degree of COVID-19 severity and mortality in stroke: correlation of clinical and laboratory parameters","volume":"25","author":"Gofir A","year":"2024","unstructured":"Gofir A, Satriotomo I, Syamsah YC, et al.. Degree of COVID-19 severity and mortality in stroke: correlation of clinical and laboratory parameters. BMC Neurosci. 2024, 25:4. 10.1186\/s12868-023-00837-w","journal-title":"BMC Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106591","article-title":"COVID-19 and stroke recurrence by subtypes: a propensity-score matched analyses of stroke subtypes in 44,994 patients","volume":"31","author":"Nia AM","year":"2022","unstructured":"Nia AM, Srinivasan VM, Lall RR, Kan P. COVID-19 and stroke recurrence by subtypes: a propensity-score matched analyses of stroke subtypes in 44,994 patients. J Stroke Cerebrovasc Dis. 2022, 31:106591. 10.1016\/j.jstrokecerebrovasdis.2022.106591","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1245_21","article-title":"An interesting case of COVID-19 with transient ischemic attack as a delayed neurological complication","volume":"11","author":"Singh J","year":"2022","unstructured":"Singh J, Robinson S. An interesting case of COVID-19 with transient ischemic attack as a delayed neurological complication. J Family Med Prim Care. 2022, 11:3302-3. 10.4103\/jfmpc.jfmpc_1245_21","journal-title":"J Family Med Prim Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/10760296241240748","article-title":"Sex differences and clinical outcomes of patients with coronavirus disease 2019 infection and cerebral venous sinus thrombosis: a systematic review","volume":"30","author":"Algarni SA","year":"2024","unstructured":"Algarni SA, ALhasab NS, Alharbi MS, Albarrak A, Alanezi AA, Al Shehri HM. Sex differences and clinical outcomes of patients with coronavirus disease 2019 infection and cerebral venous sinus thrombosis: a systematic review. Clin Appl Thromb Hemost. 2024, 30:10.1177\/10760296241240748","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282045","article-title":"The impact of SARS-CoV-2 infection on the outcome of acute ischemic stroke-a retrospective cohort study","volume":"18","author":"Tak\u00e1cs TT","year":"2023","unstructured":"Tak\u00e1cs TT, Berki \u00c1J, B\u00f6jti PP, et al.. The impact of SARS-CoV-2 infection on the outcome of acute ischemic stroke-a retrospective cohort study. PLoS One. 2023, 18:e0282045. 10.1371\/journal.pone.0282045","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106716","article-title":"A \"post-mortem\" of COVID-19-associated stroke: a case-control study","volume":"31","author":"Immovilli P","year":"2022","unstructured":"Immovilli P, Marchesi E, Terracciano C, et al.. A \"post-mortem\" of COVID-19-associated stroke: a case-control study. J Stroke Cerebrovasc Dis. 2022, 31:106716. 10.1016\/j.jstrokecerebrovasdis.2022.106716","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05299-8","article-title":"The relationship between COVID-19's severity and ischemic stroke: a systematic review and meta-analysis","volume":"42","author":"Lu Y","year":"2021","unstructured":"Lu Y, Zhao JJ, Ye MF, Li HM, Yao FR, Kong Y, Xu Z. The relationship between COVID-19's severity and ischemic stroke: a systematic review and meta-analysis. Neurol Sci. 2021, 42:2645-51. 10.1007\/s10072-021-05299-8","journal-title":"Neurol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6920","article-title":"COVID-19 severity and stroke: correlation of imaging and laboratory markers","volume":"42","author":"Katz JM","year":"2021","unstructured":"Katz JM, Libman RB, Wang JJ, et al.. COVID-19 severity and stroke: correlation of imaging and laboratory markers. AJNR Am J Neuroradiol. 2021, 42:257-61. 10.3174\/ajnr.A6920","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04041-7","article-title":"Association between SARS-CoV-2 and stroke: perspectives from a metaumbrella-review","volume":"25","author":"de Souza AM","year":"2025","unstructured":"de Souza AM, de Ara\u00fajo EF, Junior NC, Raimundo AC, Pereira AC, de Castro Meneghim M. Association between SARS-CoV-2 and stroke: perspectives from a metaumbrella-review. BMC Neurol. 2025, 25:97. 10.1186\/s12883-025-04041-7","journal-title":"BMC Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102939","article-title":"Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study","volume":"59","author":"Shahjouei S","year":"2020","unstructured":"Shahjouei S, Naderi S, Li J, et al.. Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study. EBioMedicine. 2020, 59:102939. 10.1016\/j.ebiom.2020.102939","journal-title":"EBioMedicine"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin C","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, et al.. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020, 71:762-8. 10.1093\/cid\/ciaa248","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu Y","year":"2020","unstructured":"Wu Y, Xu X, Chen Z, et al.. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020, 87:18-22. 10.1016\/j.bbi.2020.03.031","journal-title":"Brain Behav Immun"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301811","article-title":"Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension","volume":"113","author":"Xia H","year":"2013","unstructured":"Xia H, Sriramula S, Chhabra KH, Lazartigues E. Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. Circ Res. 2013, 113:1087-96. 10.1161\/CIRCRESAHA.113.301811","journal-title":"Circ Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034388","article-title":"Inflammation and stroke risk: a new target for prevention","volume":"52","author":"Kelly PJ","year":"2021","unstructured":"Kelly PJ, Lemmens R, Tsivgoulis G. Inflammation and stroke risk: a new target for prevention. Stroke. 2021, 52:2697-706. 10.1161\/STROKEAHA.121.034388","journal-title":"Stroke"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2023-0283","article-title":"Acute cerebrovascular events and inflammatory markers associated with COVID-19: An observational study","volume":"16","author":"Jumagaliyeva MB","year":"2023","unstructured":"Jumagaliyeva MB, Ayaganov DN, Abdelazim IA, Saparbayev SS, Tuychibaeva NM, Kurmambayev YJ. Acute cerebrovascular events and inflammatory markers associated with COVID-19: An observational study. J Med Life. 2023, 16:1482-7. 10.25122\/jml-2023-0283","journal-title":"J Med Life"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17986","article-title":"Neuroinflammation and anti-inflammatory therapy for ischemic stroke","volume":"9","author":"Cao Y","year":"2023","unstructured":"Cao Y, Yue X, Jia M, Wang J. Neuroinflammation and anti-inflammatory therapy for ischemic stroke. Heliyon. 2023, 9:e17986. 10.1016\/j.heliyon.2023.e17986","journal-title":"Heliyon"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-016-0470-2","article-title":"Blood\/brain biomarkers of inflammation after stroke and their association with outcome: from C-reactive protein to damage-associated molecular patterns","volume":"13","author":"Bustamante A","year":"2016","unstructured":"Bustamante A, Simats A, Vilar-Bergua A, Garc\u00eda-Berrocoso T, Montaner J. Blood\/brain biomarkers of inflammation after stroke and their association with outcome: from C-reactive protein to damage-associated molecular patterns. Neurotherapeutics. 2016, 13:671-84. 10.1007\/s13311-016-0470-2","journal-title":"Neurotherapeutics"},{"key":"ref26","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge S","year":"2010","unstructured":"Kaptoge S, Di Angelantonio E, Lowe G, et al.. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010, 375:132-40.","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.21.2479","article-title":"Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study","volume":"165","author":"Ballantyne CM","year":"2005","unstructured":"Ballantyne CM, Hoogeveen RC, Bang H, et al.. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 2005, 165:2479-84. 10.1001\/archinte.165.21.2479","journal-title":"Arch Intern Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.08.069","article-title":"High-sensitivity C-reactive protein and risk of stroke in atrial fibrillation (from the reasons for geographic and racial differences in stroke study)","volume":"118","author":"Dawood FZ","year":"2016","unstructured":"Dawood FZ, Judd S, Howard VJ, et al.. High-sensitivity C-reactive protein and risk of stroke in atrial fibrillation (from the reasons for geographic and racial differences in stroke study). Am J Cardiol. 2016, 118:1826-30. 10.1016\/j.amjcard.2016.08.069","journal-title":"Am J Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3352","article-title":"Causal relationship between lactate dehydrogenase and risk of developing ischemic stroke: a Mendelian randomized study","volume":"14","author":"Dong F","year":"2024","unstructured":"Dong F, Wang X, Li J, Zhao D, Li J. Causal relationship between lactate dehydrogenase and risk of developing ischemic stroke: a Mendelian randomized study. Brain Behav. 2024, 14:e3352. 10.1002\/brb3.3352","journal-title":"Brain Behav"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-2195","article-title":"High lactate dehydrogenase was associated with adverse outcomes in patients with acute ischemic stroke or transient ischemic attack","volume":"10","author":"Wang A","year":"2021","unstructured":"Wang A, Tian X, Zuo Y, et al.. High lactate dehydrogenase was associated with adverse outcomes in patients with acute ischemic stroke or transient ischemic attack. Ann Palliat Med. 2021, 10:10185-95. 10.21037\/apm-21-2195","journal-title":"Ann Palliat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/365910-covid-19-and-stroke-evaluating-correlations-risk-factors-and-patient-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:25:57Z","timestamp":1762442757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/365910-covid-19-and-stroke-evaluating-correlations-risk-factors-and-patient-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.96227","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}